Aurobindo Launches ADQUEY Ointment in the US
Aurobindo Pharma launched ADQUEY (difamilast 1 percent) ointment in the US through subsidiary Acrotech Biopharma and established a dedicated dermatology business.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Aurobindo Pharma unit launches ADQUEY ointment in US
Aurobindo Pharma's biopharmaceutical arm, Acrotech Biopharma Inc., has launched ADQUEY (difamilast 1%) ointment in the United States. The ointment is indicated for the treatment of mild-to-moderate atopic dermatitis in adults and pediatric patients aged 2 years and older.